For many of us who have spent years watching the Straits Times Index (STI) move with the speed of a sleepy turtle, the last two years have been nothing short of a "face-rip" rally.
After being the "underdog" for so long, seeing the STI smashing through all-time highs feels a bit surreal. If you’ve been holding our local banks and blue chips, your portfolio is likely looking the healthiest it has in a decade. But as the index cruises past the 3,600 and 3,700 levels, the "kiasu" instinct starts kicking in: Is it time to take profit, or is there still meat on the bone?
1. Top of the Cycle or a Long Overdue Re-rating?
When a market hits an all-time high (ATH), the "fear of heights" is natural. But we need to look at the fundamentals versus the noise.
The Valuation Reality: Unlike the S&P 500, which often trades on "hope" and high multiples, the STI is a "show me the money" index. Even at these levels, our banks (DBS, OCBC, UOB) aren’t exactly trading at bubble territory. Their balance sheets are fortress-like, and their CET1 ratios are healthy.
The Yield Cushion: In Singapore, we invest for the "makan" money (dividends). Even with the price run-up, the STI’s dividend yield is still hovering around a respectable 4% to 5%. Compare that to fixed deposit rates which are starting to soften, and suddenly, the "boring" STI looks like a high-yield savings account on steroids.
Verdict: This doesn't feel like a speculative "top." It feels like a global re-rating where investors are finally realizing that Singapore is a safe harbor with actual cash flow.
Where is the "Lobang"? Looking at Mid-Caps
If the STI is the "blue-chip" mansion, the Mid-Caps are the "undervalued terrace houses" in Bedok or Hougang. While the big boys have had their run, the mid-cap space is where the real value is still hiding.
For a seasoned investor, the mid-caps are attractive right now for three reasons:
The "Laggard" Play: A lot of institutional money went straight into the index heavyweights first. We are now seeing that liquidity "trickle down" to the mid-sized players in industrial REITs, offshore & marine, and tech manufacturing.
Privatization Potential: Many mid-caps are trading way below their Net Asset Value (NAV). When the market doesn't give them a fair valuation, the major shareholders often decide to "take it private" at a premium. This is a classic Singapore play—buying $1.00 worth of assets for $0.70 and waiting for the buyout offer.
Niche Moats: We have some fantastic mid-sized companies with global footprints in specialized engineering and healthcare. They don’t get the headlines, but they have the "moats" and operational excellence that long-term investors love.
Final Thoughts: Don't Fight the Trend
Is it a "top"? Maybe in the short term, we’ll see some profit-taking and a healthy pullback. But the structural story for Singapore has changed. We are no longer just a "yield play"; we are a "quality play."
The Game Plan:
Keep the core: Don't sell your winners (the banks) just because they are at ATHs. Let the dividends roll in.
Hunt for value: Look at the mid-caps that have solid earnings but haven't joined the party yet.
Stay disciplined: In Singapore, we play the long game. Focus on the corporate moats and the management’s track record.
Frencken Group (SGX: E28) & UMS Integration (SGX: 558): If you want a piece of the AI and semiconductor recovery without buying expensive US tech, these are our local proxies. Frencken, in particular, has seen massive momentum in early 2026.
Pan-United (SGX: P52): A "hidden" infrastructure play. As Singapore continues its building cycle (tunnels, Changi T5, etc.), this low-carbon concrete leader has been quietly outperforming the broader market.
Straits Trading (SGX: S20): A classic value play. They sit on a diversified pile of hospitality and resource assets. Often ignored by the masses, it’s a favorite for "asset-heavy" value hunters looking for a discount to NAV.
The STI has finally found its wings. It’s been a long wait, but for those of us who stayed the course, the view from the top is looking pretty good.
Comments